Human CaMKIIN2 ELISA Kit (Colorimetric)
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-74977
Key Product Details
Sample Type & Volume Required Per Well
Serum, plasma and other biological fluids (100 uL)
Sensitivity
0.47 ng/mL
Assay Range
0.78 - 50 ng/mL
Product Specifications
Assay Type
Sandwich-ELISA
Kit Type
ELISA Kit (Colorimetric)
Reactivity
Human
Specificity
This kit recognizes Human CAMK2N2 in samples. No significant cross-reactivity or interference between Human CAMK2N2 and analogues was observed.
Precision
Intra-Assay Precision (Precision within an assay) CV% < 5.97%
Inter-Assay Precision (Precision between assays) CV% < 4.97%
Recovery for Human CaMKIIN2 ELISA Kit (Colorimetric)
Recovery
86-108%
Linearity
Scientific Data Images for Human CaMKIIN2 ELISA Kit (Colorimetric)
ELISA: Human CaMKIIN2 ELISA Kit (Colorimetric) [NBP2-74977] -
ELISA: Human CaMKIIN2 ELISA Kit (Colorimetric) [NBP2-74977] - Standard Curve ReferenceKit Contents for Human CaMKIIN2 ELISA Kit (Colorimetric)
- Biotinylated Detection Ab Diluent
- Concentrated Biotinylated Detection Ab (100x)
- Concentrated HRP Conjugate (100x)
- Concentrated Wash Buffer (25x)
- HRP Conjugate Diluent
- Micro ELISA Plate (Dismountable)
- Plate Sealer
- Product Manual
- Reference Standard
- Sample Diluent
- Stop Solution
- Substrate Reagent
Preparation and Storage
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Storage of components varies. See protocol for specific instructions.
Background: CaMKIIN2
Alternate Names
calcium/calmodulin-dependent protein kinase II inhibitor 2, CaM-KII inhibitory protein, CAMKIIN, CaM-KIIN
Gene Symbol
CAMK2N2
Additional CaMKIIN2 Products
Product Documents for Human CaMKIIN2 ELISA Kit (Colorimetric)
Product Specific Notices for Human CaMKIIN2 ELISA Kit (Colorimetric)
This product is for research use only and is not approved for use in humans or in clinical diagnosis. ELISA Kits are guaranteed for 6 months from date of receipt.
Loading...
Loading...
Loading...
Loading...